Evidence map›Paper›PMID 33033508›Full record

ArticleJournal of Cancer2020

IL36 indicating good prognosis in human Hepatocellular Carcinoma.

Miao Hu, Ying Tong, Haisheng Fang, Jie Tang, Lang Liu, Yanni Hu, Jingze Li, Lan Zhong

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of Cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Miao HuDepartment of Gastroenterology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China, No.150 Jimo Road, Pudong New Area, Shanghai, China.
Ying TongClinical Laboratory, Cancer Hospital of Fudan University, Fudan University, Shanghai, China, No 270 Dong 'an road, Shanghai, China.
Haisheng FangDepartment of pathology, First Affiliated Hospital of Nanjing Medical University, Nanjing, China, No 300 Guangzhou road, Nanjing, China.
Jie TangDepartment of Gastroenterology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China, No.150 Jimo Road, Pudong New Area, Shanghai, China.
Lang LiuCenter of Digestive Endoscopy, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China, No.150 Jimo Road, Pudong New Area, Shanghai, China.
Yanni HuDepartment of Gastroenterology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China, No.150 Jimo Road, Pudong New Area, Shanghai, China.
Jingze LiCenter of Digestive Endoscopy, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China, No.150 Jimo Road, Pudong New Area, Shanghai, China.
Lan ZhongDepartment of Gastroenterology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China, No.150 Jimo Road, Pudong New Area, Shanghai, China.
Shanghai East Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

biomarkerHepatocellular carcinoma (HCC)interleukin 36 (IL36)prognosis

Identifiers

PMID33033508
PMCPMC7532515
OpenAlexW3084239391

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.